105 related articles for article (PubMed ID: 9933562)
1. TTC4, a novel human gene containing the tetratricopeptide repeat and mapping to the region of chromosome 1p31 that is frequently deleted in sporadic breast cancer.
Su G; Roberts T; Cowell JK
Genomics; 1999 Jan; 55(2):157-63. PubMed ID: 9933562
[TBL] [Abstract][Full Text] [Related]
2. Genomic structure of the human tetratricopeptide repeat-containing gene, TTC4, from chromosome region 1p31 and mutation analysis in breast cancers.
Su G; Casey G; Cowell JK
Int J Mol Med; 2000 Feb; 5(2):197-200. PubMed ID: 10639601
[TBL] [Abstract][Full Text] [Related]
3. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
Nagai H; Negrini M; Carter SL; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
Cancer Res; 1995 Apr; 55(8):1752-7. PubMed ID: 7712484
[TBL] [Abstract][Full Text] [Related]
4. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
[TBL] [Abstract][Full Text] [Related]
6. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
[TBL] [Abstract][Full Text] [Related]
7. Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer.
Hoggard N; Hey Y; Brintnell B; James L; Jones D; Mitchell E; Weissenbach J; Varley JM
Genomics; 1995 Nov; 30(2):233-43. PubMed ID: 8586422
[TBL] [Abstract][Full Text] [Related]
8. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
9. Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer.
Liu Y; Emilion G; Mungall AJ; Dunham I; Beck S; Le Meuth-Metzinger VG; Shelling AN; Charnock FM; Ganesan TS
Oncogene; 2002 Jan; 21(3):387-99. PubMed ID: 11821951
[TBL] [Abstract][Full Text] [Related]
10. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
[TBL] [Abstract][Full Text] [Related]
11. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
[TBL] [Abstract][Full Text] [Related]
12. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human homologue of RAD54: a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors.
Rasio D; Murakumo Y; Robbins D; Roth T; Silver A; Negrini M; Schmidt C; Burczak J; Fishel R; Croce CM
Cancer Res; 1997 Jun; 57(12):2378-83. PubMed ID: 9192813
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
Amler LC; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee WK; Schwab M; Hampton GM
Genomics; 2000 Mar; 64(2):195-202. PubMed ID: 10729226
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma.
Simon-Kayser B; Scoul C; Renaudin K; Jezequel P; Bouchot O; Rigaud J; Bezieau S
Genes Chromosomes Cancer; 2005 May; 43(1):83-94. PubMed ID: 15723337
[TBL] [Abstract][Full Text] [Related]
16. Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs.
Boultwood J; Fidler C; Strickson AJ; Watkins F; Kostrzewa M; Jaju RJ; Müller U; Wainscoat JS
Genomics; 2000 May; 66(1):26-34. PubMed ID: 10843801
[TBL] [Abstract][Full Text] [Related]
17. A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.
Baysal BE; Willett-Brozick JE; Taschner PE; Dauwerse JG; Devilee P; Devlin B
Eur J Hum Genet; 2001 Feb; 9(2):121-9. PubMed ID: 11313745
[TBL] [Abstract][Full Text] [Related]
18. Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23.
Wang JC; Radford DM; Holt MS; Helms C; Goate A; Brandt W; Parik M; Phillips NJ; DeSchryver K; Schuh ME; Fair KL; Ritter JH; Marshall P; Donis-Keller H
Genomics; 1999 Aug; 60(1):1-11. PubMed ID: 10458905
[TBL] [Abstract][Full Text] [Related]
19. Cloning and Expression Analysis of a Novel Gene, UBAP1, Possibly Involved in Ubiquitin Pathway.
Qian J; Zhang XH; Yang JB; Wang JR; Zhang BC; Tang K; Li GY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2001; 33(2):147-152. PubMed ID: 12050802
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
